Wilms tumor 1 expression in vascular neoplasms and vascular malformations

American Journal of Dermatopathology

Volumn 33, Issue 6, 2011, Pages 569-572

  Trindade, Felicidade ^a,e   Tellechea, Óscar ^b   Torrelo, Antonio ^c   Requena, Luis ^d   Colmenero, Isabel ^c  

^a Hospital de Cascais Dr José de Almeida   (Portugal)

^b CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^c HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

^d Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^e Hospital de Cascais Dr José de Almeida   (Portugal)

Author keywords

vascular malformations; vascular neoplasms; Wilms tumor 1

Indexed keywords

GLUCOSE TRANSPORTER 1; WT1 PROTEIN;

ARTERIOVENOUS MALFORMATION; ARTICLE; CAPILLARY HEMANGIOMA; CAPILLARY MALFORMATION; CONTROLLED STUDY; CYTOPLASM; ENDOTHELIUM CELL; HEMANGIOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHATIC MALFORMATION; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; NONINVOLUTING CONGENITAL HEMANGIOMA; PERIPHERAL BLOOD VESSEL MALFORMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYOGENIC GRANULOMA; RAPIDLY INVOLUTING CONGENITAL HEMANGIOMA; RETROSPECTIVE STUDY; SPINDLE CELL HEMANGIOMA; TUFTED ANGIOMA; VASCULAR TUMOR;

GLUCOSE TRANSPORTER TYPE 1; HEMANGIOMA; HUMANS; NEOPLASM STAGING; NUCLEAR PROTEINS; RETROSPECTIVE STUDIES; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; VASCULAR MALFORMATIONS; VASCULAR NEOPLASMS;

EID: 79961210110     PISSN: 01931091     EISSN: 15330311     Source Type: Journal    
DOI: 10.1097/DAD.0b013e3182092527     Document Type: Article

References (18)

1. Drolet BA, Esterley NB, Frieden IJ. Hemangiomas in clildren. N Engl J Med. 1999;341:173-181.
2. Bruckner AL, Frieden IJ. Hemangiomas of infancy. J Am Acad Dermatol. 2003:48:477-493. (Pubitemid 36397008)
3. Enjolras O, Mulliken JB. Vascular tumors and vascular malformations (new issues). Adv Dermatol. 1997;13:375-423.
4. North PE, Waner M, Mizeracki A, et al. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol. 2000;31:11-22. (Pubitemid 30054381)
5. North PE, Waner M, Mizeracki A, et al. A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. Arch Dermatol. 2001;137:559-570. (Pubitemid 32458438)
6. Lawley LP, Cerimele F, Weiss SW, et al. Expression of Wilms tumor 1 gene distinguishes vascular malformations from proliferative endothelial lesions. Arch Dermatol. 2005;141:1297-1300. (Pubitemid 41498928)
7. Enjolras O, Wassef M, Chapot R. Color atlas of vascular tumors and vascular malformations. New York, NY: Cambridge University Press; 2007:24-25.
8. Moore MAS. Putting the neo into neoangiogenesis. J Clin Invest. 2002; 109:313-213.
9. Timár J, Mészáros L, Orosz Z, et al. WT1 expression in angiogenic tumours of the skin. Histopathology. 2005;47:67-73. (Pubitemid 40978815)
10. Ellisen LW, Carlesso N, Cheng T, et al. The Wilms tumor suppressor WT1 directs stage-specific quiescence and differentiation of human hemato-poietic progenitor cells. EMBO J. 2001;20:1897-1909. (Pubitemid 32397392)
11. Nowakowska-Kopera A, Sacha T, Florek I, et al. Wilms': tumor gene 1 expression analysis by real-time quantitative polymerase chain reaction for monitoring of minimal residual disease in acute leukaemia. Leuk Lymphoma. 2009;50:1326-1332.
12. Gupta S, Joshi K, Wig JD, et al. High frequency of loss of allelic integrity at Wilms': tumor suppressor gene-1 locus in advanced breast tumors associated with aggressiveness of the tumor. Indian J Cancer. 2009;46:303-310.
13. Perry BN, Cohen C, Govindarajan B, et al. Wilms tumor 1 expression present in most melanomas but nearly absent in nevi. Arch Dermatol. 2006;142:1031-1034. (Pubitemid 44268481)
14. Oji Y, Kitamura Y, Kamino E, et al. WT1 IgG antibody for early detection of nonsmall cell lung cancer and as its prognostic factor. Int J Cancer. 2009;125:381-387.
15. Ohno S, Dohi S, Ohno Y, et al. Immunohistochemical detection of WT1 protein in endometrial cancer. Anticancer Res. 2009;29:1691-1695.
16. Hashimoto N, Tsuboi A, Chiba Y, et al. Immunotherapy targeting the Wilms' tumor 1 gene product for patients with malignant brain tumors. Brain Nerve. 2009;61:805-814.
17. Oka Y, Tsuboi A, Fujiki F, et al. WT1 peptide vaccine as a paradigm for "cancer antigen-derived peptide"-based immunotherapy for malignancies: successful induction of anti-cancer effect by vaccination with a single kind of WT1 peptide. Anticancer Agents Med Chem. 2009;9:787-797.
18. Rafii S, Lyden D, Benezra R, et al. Vascular and hamatopoietic stem cells: novel targets for anti-angiogenesis therapy? Nat Rev Cancer. 2002;2: 826-835. (Pubitemid 37328901)